In a paper published on Dec. 01/2011, Dr. Cichowski MD (fellow in female pelvic medicine and reconstructive surgery, University of New Mexico) and Dr. Rogers MD (professor and director, Division of Urogynecology, and director, Fellowship in Female Pelvic Medicine and Reconstructive Surgery, University of New Mexico) concluded that «pelvic floor rehabilitation for pelvic floor disorders is highly efficacious and provides a low - risk option for patients
with gynecologic problems.
She beat the disease and is now working
with the Gynecologic Cancer Foundation to educate women about human papillomavirus (HPV)-- a group of viruses that cause the vast majority of cervical cancer cases — and the importance of regular Pap tests to screen for cervical cancer.
The Gynecologic Cancer Program provides complete and compassionate care for women
with gynecologic cancers including ovarian, uterine, cervical, vulvar, peritoneal, and fallopian tube cancers, as well as gestational trophoblastic disease.
Minimally invasive and robotic surgery is now used for treatment of a majority of women
with gynecologic cancer.
Rodriguez - Rodriguez L, Hirshfield KM, Rojas V, DiPaola RS, Gibbon D, Hellmann M, Isani S, Leiser A, Riedlinger GM, Wagreich A, Ali SM, Elvin JA, Miller VA, Ganesan S. Use of comprehensive genomic profiling to direct point - of - care management of patients
with gynecologic cancers.
To learn more about current immunotherapy treatment options for women
with gynecologic cancers, and how close we are to making these treatments available to more patients, watch Dr. Odunsi's webinar from June 4, 2013.
«We encourage clinical trial participation in the hopes that we will improve the outcome for our patients
with gynecologic malignancies.»
As part of an ongoing clinical trial at Rutgers Cancer Institute exploring rare and poor prognosis cancers, investigators sought to identify genomic alterations in 69 patients
with gynecologic cancers that were not responding to standard care.
«Based on our estimates, it's likely that more than 7,000 women
with gynecologic cancers per year experience distance - related barriers to accessing appropriate care from a specialist.
A urine pregnancy test, drawn with the help of a bladder catheter, confirmed that diagnosis, and I was called down
with the gynecologic surgery team.
An oral cancer drug improves outcomes while minimizing side effects in women
with gynecologic cancers who carry a BRCA mutation and whose disease is not responding to other therapies, suggests preliminary research.
GYN Cancer Support Group - For patients who are diagnosed
with a gynecologic cancer.
Not exact matches
Be easy and don't push yourself too hard,» advises Mark Moore, M.D., an anesthesiologist in Tallahassee, Fla.,
with a sub-specialization in obstetric and
gynecologic anesthesia.
Optimal
gynecologic and obstetric care for women
with epilepsy requires a multidisciplinary approach throughout the various life stages.
This article discusses these effects and makes recommendations for
gynecologic and obstetric care of patients
with epilepsy,
with particular focus on pregnancy.
The mission of the American College of Nurse - Midwives is to support midwives and advance the practice of midwifery in order to achieve optimal health for women through their lifespan,
with expertise in well woman and
gynecologic care, promoting optimal pregnancy, physiologic birth, postpartum care, and care of the newborn.
Ludington - Hoe, S. «Breast Infant Temperature
with Twins during shared Kangaroo Care,» 2006 Journal of Obstetric,
Gynecologic and Neonatal Nursing, 35 (2) 223 - 231
Cervical cancer is the easiest
gynecologic cancer to prevent
with regular screening test and follow - up.
«Although FDA approval is critically important for introducing a new screening test or algorithm, providers ultimately rely on guidance or guidelines to help them make the best decisions for their patients and want to understand advantages, disadvantages and unknowns associated
with a new screening approach,» said Huh, who is a senior scientist for the UAB Comprehensive Cancer Center, Director of the UAB Division of
Gynecologic Oncology, and is also a board member for both the American Society for Colposcopy and Cervical Pathology and the Society of
Gynecologic Oncology.
«Estimating from various studies that looked at increasing BMI and endometrial cancer risk, a woman
with a Body Mass Index (BMI) of 40 would have approximately eight times greater risk of endometrial cancer than someone
with a BMI of 25,» said first author Kristy Ward, MD, the senior
gynecologic oncology fellow in the Department of Reproductive Medicine at UC San Diego School of Medicine.
«While the presence of lymphocytes in tumors is often associated
with better clinical outcomes, this research adds clarity on the diversity of T cells within the tumor environment and their influence on ovarian cancer outcomes,» says first author Kunle Odunsi, MD, PhD, FRCOG, FACOG, Deputy Director, M. Steven Piver Professor and Chair of
Gynecologic Oncology, and Executive Director of the Center for Immunotherapy at Roswell Park.
TRINOVA - 2 is evaluating pegylated liposomal doxorubicin in combination
with either placebo or trebananib in previously treated patients
with ovarian cancer while TRINOVA - 3, also known as ENGOT - Ov2 and
Gynecologic Oncology Group — 3001, is studying the use of trebananib in front - line treatment adding it to carboplatin / paclitaxel.
«We found that pemetrexed combined
with cisplatin is less toxic, well tolerated, and should be developed for further treatment of cervical cancer,» said
gynecologic oncology specialist Dr. David Miller, Professor of Obstetrics and Gynecology and a member of the Harold C. Simmons Cancer Center.
«Given that pemetrexed combined
with cisplatin may be less toxic than and as active as cisplatin plus paclitaxel and that it can be combined
with bevacizumab, investigating the comparison of cisplatin - pemetrexed plus bevacizumab
with cisplatin - paclitaxel plus bevacizumab would be the next appropriate step,» said Dr. Miller, who holds the Amy and Vernon E. Faulconer Distinguished Chair in Medical Science and the Dallas Foundation Chair in
Gynecologic Oncology.
The USPSTF found inadequate evidence on the benefits of screening for a range of
gynecologic conditions
with pelvic examination.
Very few studies on screening for other
gynecologic conditions
with pelvic examination alone have been conducted, and the USPSTF found that these studies have limited generalizability to the current population of asymptomatic women seen in primary care settings in the United States.
«Evidence insufficient regarding screening for
gynecologic conditions
with pelvic examination.»
The study showed 123 referral networks nationally that do not have access to a
gynecologic oncologist, suggesting women would have to travel outside of their referral network to be connected
with a specialist.
Shalowitz and colleagues suggest future studies should focus on defining areas
with poor clinical outcomes attributed to geographic factors, and creating a comprehensive national, geographically - linked database on the utilization of
gynecologic cancer care and clinical outcomes.
The counties
with the greatest number of
gynecologic oncologists within 50 miles are located near major metropolitan areas, primarily along the Atlantic coast between Atlanta and Boston.
Our findings suggest that abstinence from regular physical activity is associated
with increased odds of cervical cancer,» says J. Brian Szender, MD, MPH, lead author of the study and a fellow in the Department of
Gynecologic Oncology at Roswell Park.
For women
with ovarian cancer, a particularly deadly form of
gynecologic cancer, even improvements in treatment outcomes have been elusive.
The four - year study involved 461 patients at 24 medical oncology clinics at Princess Margaret Cancer Centre, University Health Network (UHN)
with advanced lung, gastrointestinal, genitourinary, breast and
gynecologic cancers.
Cervical cancer is the third most common
gynecologic cancer in the United States, and takes the life of one of every three women diagnosed
with it.
,» Louise P. King, a
gynecologic surgeon
with a focus on infertility, explores the extent to which clinicians in reproductive medicine should follow patient requests that they disagree
with or instead try to persuade the patient to choose a different option.
This study adds to the discussion about the role of this immunosurveillance in the risk of developing the common cancers among those
with compromised immune systems,» adds first author Paul Mayor, MD, Fellow in the Department of
Gynecologic Oncology at RPCI.
«Unfortunately, due to the lack of screening mechanisms for many
gynecologic cancers, they are often diagnosed in an advanced stage, thus leading to poor treatment response
with standard therapies in many cases.
Women
with Stage III ovarian cancer given a combination of intravenous and intraperitoneal chemotherapy following surgical debulking of tumor had a median survival nearly 16 months longer than women who received IV chemotherapy alone, according to a study published conducted by the
Gynecologic Oncology Group (GOG), a National Cancer Institute - supported research network, in the January 5, 2006 issue of the New England Journal of Medicine.
The University of Chicago's multidisciplinary team of
gynecologic oncologists, medical oncologists, radiation oncologists, and pathologists «will continue to be committed to providing patients
with as many pre - and post-surgical treatment options as possible,» Yamada said.
«We've known for years that how well a patient does is directly related to the amount of tumor that the surgeon removes and the amount that's left behind,» says Michael Birrer, who began working
with Belcher when he was head of medical
gynecologic oncology at Massachusetts General Hospital.
I am a board - certified
gynecologic oncologist who specializes in the surgical treatment of women
with known or suspected ovarian and endometrial cancers.
The results suggest that assessing baseline QoL in women
with PRR - ROC might help identify which patients are unlikely to benefit from palliative chemotherapy, said lead study author Felicia Roncolato, MBChB, FRACP, of St. George Hospital in Sydney, Australia, on behalf of the
Gynecologic Cancer Intergroup Symptom Benefit Group.
The registry tracks the medical history of patients
with specific
gynecologic cancers who may have been exposed to diethylstilbestrol (DES) or other synthetic hormones while still in their mother's womb.
At UT Southwestern Medical Center, our
gynecologic cancer experts have unmatched expertise in treating patients
with ovarian cancer.
«Visualizing how cancer cells interact
with a tumor microenvironment that accurately reflects the complex biology of ovarian cancer should help us understand the mechanisms underlying metastatic progression as well as identify new therapeutics that can inhibit this process,» said clinical
gynecologic oncologist Ernst Lengyel, MD, PhD, senior author of the study and a professor of obstetrics and gynecology at the University of Chicago.
Our specialists are experienced in detecting and treating
gynecologic cancers
with the latest medical and surgical treatments.
We are in an exciting era of discoveries and advances in cancer treatment, specifically
with regard to
gynecologic cancers.
RESEARCH INTERESTS: The Drapkin laboratory focuses on developing a comprehensive understanding of the genetic, molecular and physiological factors that drive the development of cancer,
with a special focus on
gynecologic malignancies.
Every year, 10,000 U.S. women are diagnosed
with cervical cancer, and 3,600 die from the disease, according to Debbie Saslow, PhD, director of breast and
gynecologic cancer at the American Cancer Society in Atlanta.
For more information on CAH, see: A Commonly Missed Cause of Infertility, NonClassical CAH by Jeffrey Dach MD (78) Articles
with Related Interest PCOS Part Two PCOS Part three Jeffrey Dach MD 7450 Griffin Rd Suite 180/190 Davie, FL 33314 Phone: 954-792-4663 Facebook Blog REFERENCES (1) http://www.amazon.com/Clinical-
Gynecologic-Endocrinology-Infertility-Editorial/dp/0781747953 The Clinical
Gynecologic Endocrinology and Infertility: Leon Speroff MD (2) http://jcem.endojournals.org/cgi/content/full/88/5/1927 A Modern Medical Quandary: Polycystic Ovary Syndrome, Insulin Resistance, and Oral Contraceptive Pills, The Journal of Clinical Endocrinology & Metabolism Vol.